[Dosage adjustment of vancomycin in continuous infusion in critically ill-patients]

Ann Fr Anesth Reanim. 2010 Jan;29(1):55-7. doi: 10.1016/j.annfar.2009.12.002. Epub 2010 Jan 13.
[Article in French]

Abstract

Introduction: As the susceptibility of staphylococcal strains to glycopeptides rises, it is becoming necessary to increase vancomycin dosages.

Objective: To evaluate an administration protocol for vancomycin using continuous infusion with a loading dose of 30 mg/kg followed by 30 mg/kg per 24h in intensive care patients presenting creatinine clearance (CLc) greater than 50.

Results: A total of 22 patients were included in the study. Serum vancomycin concentrations after 24h (C24h) ranged from 25 to 30 mg/l in seven of 14 patients with CLc less than 120 ml/min (50 %), compared with three patients (21 %) with C24h greater than 35 mg/l and four patients (29 %) with C24 h less than 25 mg/l. However, C24h was less than 20mg/l for the eight patients with CLc greater or equal to 120 ml/min. Bacteriological data was available for eight of the 14 patients with CLc less than 120 ml/min, and in these eight patients, the C24h/MIC was greater or equal to 8; seven of these patients had an AUC/MIC greater or equal to 350.

Conclusion: Assay of serum vancomycin concentrations after 24h of treatment is necessary to enable rapid adjustment of vancomycin concentration in order to improve therapeutic efficacy or avoid nephrotoxicity.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / therapeutic use
  • Clinical Protocols
  • Critical Care / methods*
  • Critical Illness*
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Dose-Response Relationship, Drug
  • Drug Monitoring
  • Hospitals, University
  • Humans
  • Infusions, Intravenous
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Recovery Room
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control
  • Staphylococcus epidermidis / drug effects
  • Staphylococcus epidermidis / isolation & purification
  • Staphylococcus haemolyticus / drug effects
  • Staphylococcus haemolyticus / isolation & purification
  • Vancomycin / administration & dosage*
  • Vancomycin / blood
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin